|1.||Mackness, Bharti: 25 articles (12/2013 - 08/2002)|
|2.||Erel, Ozcan: 22 articles (09/2015 - 03/2007)|
|3.||Camps, Jordi: 18 articles (12/2013 - 05/2002)|
|4.||Joven, Jorge: 18 articles (12/2013 - 05/2002)|
|5.||Aksoy, Nurten: 16 articles (12/2014 - 01/2008)|
|6.||Reddy, Srinivasa T: 14 articles (11/2013 - 09/2003)|
|7.||Aslan, Mehmet: 13 articles (09/2015 - 03/2007)|
|8.||Marsillach, Judit: 13 articles (12/2013 - 11/2005)|
|9.||Celik, Hakim: 13 articles (10/2013 - 01/2007)|
|10.||Gugliucci, Alejandro: 11 articles (01/2015 - 02/2007)|
04/01/2003 - "Paraoxonase 1, an HDL-associated enzyme that confers antioxidant activity on HDL, and its activity in serum have been correlated with protection against atherosclerosis, an oxidative disease. "
09/01/2014 - "Now-a-days, there are only few studies which have presented the correlation between antioxidant enzyme HDL-associated-paraoxonase 1(PON1) and Hcy in atherosclerosis. "
10/25/2010 - "Since paraoxonase enzyme (PON) is a bioscavenger against both atherosclerosis and organophosphate toxicity, studies on paraoxonase enzyme (PON) occupy an important place in the scientific world. "
06/01/2010 - "This study was designed to evaluate the paraoxonase 1 (PON1) activity and oxidant/antioxidant status in Saudi women with PCOS and its contribution to the risk of atherosclerosis. "
01/01/2010 - "In this study, a recombinant adeno-associated virus (rAAV) vector carrying the human paraoxonase-1 (hPON1) gene (rAAV-PON1) was constructed, and endothelial progenitor cells (EPCs) transfected with rAAV-PON1 were transplanted into the atherosclerosis model of Sprague-Dawley rats (SD rats). "
04/01/1995 - "These results indicate that exogenous paraoxonase offers significant protection against CPS toxicity when administered both before and after the organophosphate, suggesting that it may be considered as a potential additional treatment of organophosphate poisoning."
10/01/1993 - "A number of lines of evidence suggest that serum paraoxonase is protective against poisoning by organophosphorus substrates of this enzyme. "
04/01/1997 - "The increase of serum paraoxonase activity in developing animals correlates well with the increased resistance to organophosphate poisoning that has been reported in previous studies."
07/01/2015 - "[Role and significance of paraoxonase in acute organophosphate poisoning]."
04/01/2011 - "To provide toxicokinetic and clinical evidence of the hydrolytic effect of paraoxonase-1 (PON1) on acute organophosphate poisoning in rats. "
|3.||Coronary Artery Disease (Coronary Atherosclerosis)
01/01/2014 - "Previous studies have shown an association between paraoxonase (PON) activity and the presence and severity of coronary atherosclerosis. "
06/01/2012 - "The aim of this study was to investigate serum paraoxonase-1 enzyme activity (SPA) in patients with CAE in comparison patients with coronary artery disease (CAD) and normal coronary arteries. "
01/01/2012 - "Previous studies examined associations between polymorphisms in the paraoxonase 1 (PON1) gene and development of coronary artery disease (CAD), with inconsistent results. "
03/01/2009 - "A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease."
01/01/2009 - "Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study."
|4.||Coronary Disease (Coronary Heart Disease)
10/01/2004 - "The antioxidant enzyme paraoxonase 1 (PON1) has previously been suggested to confer protection against coronary heart disease (CHD), one of the main causes of death in the Western world. "
06/01/1997 - "Recent studies have implicated paraoxonase, an HDL-associated enzyme, in providing protection against LDL oxidation, thus affecting the risk of coronary heart disease (CHD) in the general population. "
07/01/2009 - "Previous studies of genetic variants of paraoxonase 1 (PON1) and coronary heart disease (CHD) have been conflicting and the modifying effects of lifestyle factors that affect PON1 activity are uncertain. "
04/01/2008 - "Paraoxonase activity and coronary heart disease risk in healthy middle-aged males: the PRIME study."
02/28/2004 - "Although there have been suggestions that serum paraoxonase is important in protecting against coronary heart disease (CHD), a large number of studies of genetic determinants of serum paraoxonase have reported apparently conflicting results about their association with CHD. "
|5.||Cardiovascular Diseases (Cardiovascular Disease)
03/01/2000 - "Recent studies indicate that the enzyme paraoxonase may be an important modulator of cardiovascular disease risk because of its ability to protect LDL from oxidation. "
01/01/1997 - "Paraoxonase was identified as a genetic risk factor for cardiovascular disease (CVD) in recent studies focusing on a polymorphism affecting position 191. "
10/01/2015 - "Decreased activity of the enzyme paraoxonase-1 (PON1) has been demonstrated in cardiovascular diseases. "
01/01/2015 - "Review: The role of paraoxonase in cardiovascular diseases."
12/01/2014 - "Recently, ample evidence has suggested a common etiologic factor, namely, reduced HDL-associated paraoxonase 1 (PON1) activity, as a causative factor in the development of PMOP and cardiovascular disease (CVD). "
|2.||Renal Dialysis (Hemodialysis)
|5.||Continuous Ambulatory Peritoneal Dialysis (CAPD)